Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Acta Diabetol. 2014 Jun 15;51(5):783–791. doi: 10.1007/s00592-014-0611-1

Table 3.

C-statistics for Models with SUA, SBP, DBP, HbA1c and LDL-C as Continuous Variables

Model 1 (HbA1c, SBP, DBP and LDL-C) vs. model 2 (model 1 + SUA)
Models AUC (95% CI) ΔAUC IDI (±SE) Relative IDI* (%)
CAC progression (n=199)
Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.67 (0.62–0.73)
Model 1 + SUA (model 1: HbA1c, SBP, DBP and LDL-C) 0.72 (0.68–0.77)
SUA + Model 1 vs Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.05 (p=0.005) 0.05±0.01 (p<0.0001) 12.2% (p<0.0001)
Incident albuminuria (n=27)
Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.67 (0.55–0.80)
Model 1 + SUA (model 1: HbA1c, SBP, DBP and LDL-C) 0.73 (0.61–0.84)
SUA + Model 1 vs Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.06 (p=0.20) 0.04±0.02 (p=0.02) 35.1% (p=0.02)
Rapid GFR decline (n=50)
Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.69 (0.60–0.77)
Model 1 + SUA (model 1: HbA1c, SBP, DBP and LDL-C) 0.70 (0.62–0.79)
SUA + Model 1 vs Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.02 (p=0.27) 0.01±0.01 (p=0.11) 6.5% (p=0.11)
Incident diabetic retinopathy (n=71)
Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.65 (0.58–0.72)
Model 1 + SUA (model 1: HbA1c, SBP, DBP and LDL-C) 0.68 (0.61–0.75)
SUA + Model 1 vs Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.03 (p=0.19) 0.02±0.01 (p=0.01) 14% (p=0.01)
Incident peripheral diabetic retinopathy (n=35)
Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.73 (0.64–0.82)
Model 1 + SUA (model 1: HbA1c, SBP, DBP and LDL-C) 0.77 (0.69–0.86)
SUA + Model 1 vs Model 1 (model 1: HbA1c, SBP, DBP and LDL-C) 0.04 (p=0.31) 0.05±0.02 (p=0.01) 38% (p=0.01)
*

Relative IDI – calculated as the ratio of IDI over the discrimination slope of the model without the new variable (i.e. SUA).